Jazz Pharmaceuticals Spikes In #PreMarket On Q2 Beat; Boosts Revenue Outlook

By: via Benzinga
Jazz Pharmaceuticals (NASDAQ: JAZZ) shares spiked as much as three percent before retreating in pre-market trading Tuesday after the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.